Advertisement
Canada markets open in 3 hours 59 minutes
  • S&P/TSX

    22,107.08
    +194.56 (+0.89%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CAD/USD

    0.7347
    -0.0025 (-0.34%)
     
  • CRUDE OIL

    81.62
    +0.27 (+0.33%)
     
  • Bitcoin CAD

    96,201.84
    +1,142.07 (+1.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,195.10
    +4.50 (+0.21%)
     
  • RUSSELL 2000

    2,114.35
    +44.19 (+2.13%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,468.25
    -35.50 (-0.19%)
     
  • VOLATILITY

    12.98
    +0.20 (+1.57%)
     
  • FTSE

    7,961.96
    +29.98 (+0.38%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6812
    +0.0007 (+0.10%)
     

Company News For Nov 20, 2018

  • Cimarex Energy Co.’s XEC shares declined 0.8% following reports that the oil and gas company would be acquiring Resolute Energy Corporation REN for $35 per share in cash and stock

  • Shares of Spectrum Brands Holdings, Inc. SPB plummeted 19% after the company reported fourth-quarter fiscal 2018 earnings of $0.79 per share, missing the Zacks Consensus Estimate of $1.13 per share

  • Walgreens Boots Alliance, Inc.’s WBA shares fell 0.7% after the state of Florida sued the company accusing it of not taking precautionary measures to stop illegal sales of opioids

  • Shares of Colfax Corporation CFX declined 15.2% after the company shared plans of acquiring DJO Global for $3.15 billion in cash


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Colfax Corporation (CFX) : Free Stock Analysis Report
 
Spectrum Brands Holdings Inc. (SPB) : Free Stock Analysis Report
 
Resolute Energy Corporation (REN) : Free Stock Analysis Report
 
Cimarex Energy Co (XEC) : Free Stock Analysis Report
 
Walgreens Boots Alliance, Inc. (WBA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research